Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
McKinsey
UBS
Boehringer Ingelheim
AstraZeneca
Chubb
Johnson and Johnson
Fish and Richardson
McKesson

Generated: April 22, 2018

DrugPatentWatch Database Preview

KEFLET Drug Profile

« Back to Dashboard

Which patents cover Keflet, and what generic alternatives are available?

Keflet is a drug marketed by Lilly and is included in two NDAs.

The generic ingredient in KEFLET is cephalexin. There are twenty-nine drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the cephalexin profile page.
Drug patent expirations by year for KEFLET
Medical Subject Heading (MeSH) Categories for KEFLET
Synonyms for KEFLET
(6R-(6alpha 7beta(R)))-7-((Aminophenylacetyl)amino)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid
(6R,7R)-7-((R)-2-Amino-2-phenyl-acetylamino)-3-methyl-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-((R)-2-amino-2-phenylacetamido)-3-methyl-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-((R)-2-Amino-2-phenylacetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carbonsaeure
(6R,7R)-7-((R)-2-amino-2-phenylacetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[(2R)-2-amino-2-phenylacetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[[(2R)-2-amino-2-phenyl-acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
105879-42-3 (mono-hydrochloride, mono-hydrate)
105879-42-3 (mono-hydrochloride,mono-hydrate)
14101-75-8
15686-71-2
17692-47-6
2312AH
23325-78-2 (mono-hydrate)
34632-04-7
38932-40-0 (mono-hydrochloride salt)
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2R)-aminophenylacetyl)amino)-3-methyl-8-oxo-, (6R,7R)-
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((aminophenylacetyl)amino)-3-methyl-8-oxo-, (6R-(6alpha,7beta(R*)))-
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(2-amino-2-phenylacetamido)-3-methyl-8-oxo-, D-
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-methyl-8-oxo-, (6R,7R)-
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2R)-aminophenylacetyl]amino]-3-methyl-8-oxo-, (6R,7R)-
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid, 7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-methyl-8-oxo-, (6R,7R)-
5SFF1W6677
65454-17-3
66905-57-5 (di-hydrate)
7-(D-2-Amino-2-phenylacetamido)-3-methyl-delta (sup 3)-cephem-4- carboxylic acid
7-(D-2-Amino-2-phenylacetamido)-3-methyl-delta (sup 3)-cephem-4-carboxylic acid
7-(D-2-Amino-2-phenylacetamido)-3-methyl-delta3-cephem-4-carboxylic acid
7-(D-alpha-amino-phenylacetamido)-3-methyl-3-cepheme-4-carboxylic acid
7-(D-alpha-Aminophenylacetamido)desacetoxycephalosporanic acid
7-beta-(D-alpha-Amino-alpha-phenylacetylamino)-3-methyl-3-cephem-4-carboxylic acid
7beta-[(2R)-2-amino-2-phenylacetamido]-3-methyl-3,4-didehydrocepham-4-carboxylic acid
AB0089169
AB2000126
AC1L1D8M
Ades[prex
AK322021
AKOS004119846
Alcephin
Alexin
Alsporin
AN-18582
Anhydrous cefalexin
Anhydrous cephalexin
API0001883
B1692
BCP9000509
BCPP000289
BDBM50139896
Biocef
BPBio1_000501
BRD-K90733503-002-03-6
BRN 0965503
BSPBio_000455
C-2660
C06895
Carnosporin
CAS-15686-71-2
CCG-100831
Cefa-iskia
Cefablan
Cefadal
Cefadin
Cefadina
Cefaleksin
Cefalessina
Cefalessina [DCIT]
Cefalexin
Cefalexin (JP15)
Cefalexin (JP17)
Cefalexin anhydrous
cefalexin HCl
Cefalexin hydrochloride
Cefalexin Sodium
Cefalexin, VETRANAL(TM), analytical standard
Cefalexin;Alcephin;Cefablan;keflex,Cefadin;Tepaxin
Cefalexina
Cefalexina [INN-Spanish]
Cefalexine
Cefalexine [INN-French]
Cefalexinum
Cefalexinum [INN-Latin]
Cefalin
Cefaloto
Cefaseptin
Cefax
Ceffanex
Ceflax
Ceforal
Cefovit
Celexin
Cepastar
Cepexin
Cephacillin
cephalexin
Cephalexin (anhydrous)
Cephalexin (Cefalexin)
Cephalexin [USAN:BAN]
Cephalexin 1-hydrate
Cephalexin anhydrous
Cephalexin hydrate
Cephalexin hydrochloride
Cephalexin monohydrate
Cephalexin monohydrate, Antibiotic for Culture Media Use Only
Cephalexin, (6R-(6alpha,7beta))-Isomer
Cephalexin, Antibiotic for Culture Media Use Only
Cephalexin, Pharmaceutical Secondary Standard; Certified Reference Material
Cephalexin(USP)
Cephalexine
Cephalexinum
Cephanasten
Cephaxin
Cephin
Cepol
Ceporex
Ceporex Forte
Ceporexin
Ceporexin-E
Ceporexine
CEX
CHEBI:3534
Check
CHEMBL1727
Cophalexin
CS-2137
CTK2F7346
D00263
D0Z5EM
DB00567
DSSTox_CID_2780
DSSTox_GSID_22780
DSSTox_RID_76726
DTXSID9022780
Durantel
Durantel DS
EBD56457
Ed A-Ceph
EINECS 239-773-6
Epitope ID:117132
Erocetin
Factagard
Felexin
Fexin
GTPL4832
HE310005
HMS2051A04
HSDB 3022
HY-B0200
I06-2233
Ibilex
Ibrexin
Inphalex
Kefalospes
Keflex
Keflex (TN)
Kefolan
Keforal
Keftab
Keftab (TN)
Kekrinal
Kidolex
KS-1134
L-Cephalexin
L-Keflex
Lafarine
Larixin
Lenocef
Lexibiotico
Lilly 66873
Lonflex
Lopilexin
LS-149963
LS-174191
Madlexin
Mamalexin
Mamlexin
Medoxine
MFCD00056877
MLS000759527
MLS001424036
MolPort-002-507-304
NC00081
NCGC00159522-02
NCGC00159522-03
NCGC00159522-05
Neokef
Neolexina
Novolexin
Nufex
Optocef
Oracef
Oriphex
Oroxin
Ortisporina
Ospexin
Palitrex
Panixine Disperdose
Panixine disperdose (TN)
Pectril
Prestwick0_000358
Prestwick1_000358
Prestwick2_000358
Prestwick3_000358
Pyassan
Q-200819
Roceph
Roceph Distab
S 6437
Sanaxin
Sartosona
SCHEMBL2961
Sencephalin
Sepexin
Servispor
Sialexin
Sinthecillin
SMR000338536
SPBio_002376
Sporicef
Sporidex
Sporidex (TN)
SQ 20248
Syncl
Syncle
Synecl
Tepaxin
Tokiolexin
Tox21_111740
Tox21_111740_1
UNII-5SFF1W6677
Uphalexin
Voxxim
Winlex
ZAIPMKNFIOOWCQ-UEKVPHQBSA-N
ZINC3830500
Zozarine

US Patents and Regulatory Information for KEFLET

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly KEFLET cephalexin TABLET;ORAL 050440-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lilly KEFLET cephalexin TABLET;ORAL 062745-002 Dec 1, 1986 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lilly KEFLET cephalexin TABLET;ORAL 062745-001 Dec 1, 1986 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lilly KEFLET cephalexin TABLET;ORAL 050440-003 Feb 26, 1987 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Harvard Business School
Cipla
Farmers Insurance
Fish and Richardson
Express Scripts
Julphar
Boehringer Ingelheim
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.